{"id":"W4207020757","doi":"10.1093/ecco-jcc/jjab232.671","title":"P544 Patients with moderate to severe Crohn’s disease with and without prior biologic failure demonstrated improved clinical outcomes with risankizumab: Results from phase 3 induction and maintenance trials","year":2022,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Maintenance therapy; Internal medicine; Placebo; Clinical trial; Population; Randomized controlled trial; Crohn's disease; Phases of clinical research; Gastroenterology; Disease; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003588387,0.0007224449,0.002492212,0.000287971,0.0002648078,0.0008738217,0.0004385075,0.0007440193,0.002105478],"category_scores_gemma":[0.002052117,0.0002790502,0.00313563,0.0004685255,0.000534378,0.0005461494,0.000401809,0.00106397,0.0003080228],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003289958,"about_ca_system_score_gemma":0.0006792645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004407352,"about_ca_topic_score_gemma":0.001031576,"domain_scores_codex":[0.9983163,0.0009212838,0.000213654,0.0002393715,0.0001666356,0.0001428429],"domain_scores_gemma":[0.9987041,0.0003974732,0.0004471191,0.0001539494,0.0001207075,0.0001765584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8336738,0.002311152,0.03993315,0.001977434,0.01559946,0.00016221,0.000119357,0.0005162046,0.01547343,0.000114571,0.00153388,0.08858547],"study_design_scores_gemma":[0.4774937,0.2494063,0.2321372,0.000395241,0.02620186,0.0008245614,0.0001537431,0.001206355,0.005941432,0.0005106932,0.005640567,0.0000883241],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771758,0.01839434,0.0005810142,0.0003094655,0.0001071505,0.0005770994,0.0009086988,0.00005694263,0.001889382],"genre_scores_gemma":[0.9955567,0.001985504,0.0004545941,0.0002969633,0.0001270662,0.0002805153,0.000858717,0.00000767111,0.0004323463],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003588387,"threshold_uncertainty_score":0.01897746,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01751084819762846,"score_gpt":0.2862971482357831,"score_spread":0.2687863000381546,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}